Table 1.
Oral infection of mice and passive administration of Abs.
PROPHYLACTIC SETTINGS | ||||
---|---|---|---|---|
Bacterial infection assay | ||||
Mock-treated | PBS | 150 μl | 2 × 107 St | 100 μl |
Ab-treated | IgA/M/SCIgA/M/IgG | 150 μl | 2 × 107 St | 100 μl |
Mouse survival assay | ||||
Mock-treated | PBS | 150 μl | 2 × 106 St | 100 μl |
Ab-treated | IgA/M/SCIgA/M/IgG | 150 μl | 2 × 106 St | 100 μl |
THERAPEUTIC SETTINGS | ||||
Bacterial infection assay (treatment at + 1 h only) | ||||
Mock-treated | PBS | 150 μl | 2 × 107 St | 100 μl |
Ab-treated | SCIgA/M | 150 μl | 2 × 107 St | 100 μl |
Bacterial infection assay (treatment at + 1 h or + 8 h) | ||||
Mock-treated | PBS | 150 μl | 2 × 106 St | 100 μl |
Ab-treated | SCIgA/M | 150 μl | 2 × 106 St | 100 μl |
Mouse survival assay | ||||
Mock-treated | PBS | 150 μl | 2 × 106 St | 100 μl |
Ab-treated | SCIgA/M | 150 μl | 2 × 106 St | 100 μl |